Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2025-12-24 @ 6:40 PM
NCT ID: NCT00586157
Eligibility Criteria: Inclusion Criteria: * Male and female outpatients 6 to 12 years of age. * Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), by DSM-IV, as manifested in clinical evaluation and confirmed by structured interview. * Participation in structured morning routine (e.g. school, camp, or other organized activities). Exclusion Criteria: * Mental retardation (IQ \<75). * Subjects with a medical condition, or treatment that will either jeopardize subject safety or affect the scientific merit of the study. * Subjects with moderate to severe dermatological atopy. * Subjects with known structural cardiac abnormalities. * Organic brain disorders. * Seizure Disorder. * Subjects with Tourette's syndrome, or a history of psychosis or bipolar disorder. * Subjects with current comorbid psychopathology that in the investigator's opinion will warrant immediate treatment or will interfere with the safe execution of the protocol (i.e. Anxiety or Major Depressive Disorder rated as moderate on CGI). * Subjects with a history of intolerable adverse effects or non-response to methylphenidate. * Pregnant or nursing females.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 6 Years
Maximum Age: 12 Years
Study: NCT00586157
Study Brief:
Protocol Section: NCT00586157